TRANSDERMAL DIAGNOSTICS LTD
B68/100Summary
TRANSDERMAL DIAGNOSTICS LTD is an active private limited company (company number 13566819) incorporated on 16 August 2021, registered in Bristol. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 August 2025, showing net assets of £448k, with 8 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 46% on the prior period (£832k).
By net assets it sits in the top quarter of 50 comparable companies in Bristol (median £17k, upper quartile £164k).
Key dates
- Incorporated
- 16 August 20215 yrs ago
- Next accounts due
- 31 May 2027in 221 days
- Confirmation statement due
- 30 August 2027in 312 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £448k | — | — | £548k | — | — | 8 |
| 31 August 2024 | £832k | — | — | £24k | — | — | 7 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £447,665 at 2025-08-31 |
| −8 | Net assets falling-46.2% vs prior period |
| +8 | Comfortable liquidityCurrent ratio 1.74 |
| +8 | EstablishedIncorporated 2021-08-16 (5 years) |
| 68 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
No active person with significant control is registered.
- Professor Richard Henry Guy
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr. Luca Lipani
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr. Luca Lipani
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 312 days
- Next accounts duein 221 days
- Accounts period endNet assets £448k · micro accounts
- Accounts period endNet assets £832k · micro accounts
- Incorporated
Similar companies in Bristol
- SCARLET THERAPEUTICS LIMITEDBristol · inc. Jul 2021
- CDOTBIO LIMITEDBristol · inc. Apr 2021
- NEUROCHASE TECHNOLOGIES LTDBristol · inc. Apr 2021
- NEW EARTH DEVELOPMENTS LTDBristol · inc. Dec 2020
- ANTHONI CT PARTNERS LIMITEDBath · inc. Nov 2020
- PROFUSION HEALTH LIMITEDBristol · inc. Aug 2022
All companies incorporated on 16 August 2021 · in Aug 2021.
Reminders for TRANSDERMAL DIAGNOSTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.